Finance

Lists
PBLS:NASDAQ
Parabilis Medicines Inc
$34.98
-1.69%
(-0.60) 1D
$34.98
0.00% (0.00)
After hours
Closed: Aug 7, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PBLS...
Open
$36.20
High
$36.50
Low
$34.21
Mkt. cap
4.08B
Avg. vol.
467.25K
Volume
279.89K
52-wk high
$36.82
52-wk low
$24.51
EPS
-$1.77
No. of employees
145
Open
$36.20
High
$36.50
Low
$34.21
Mkt. cap
4.08B
Avg. vol.
467.25K
Volume
279.89K
52-wk high
$36.82
52-wk low
$24.51
EPS
-$1.77
No. of employees
145
News stories
From sources across the web
About Parabilis Medicines Inc
CEO-
Employees145
Founded2015
Headquarters-
SectorBiotechnology
Websiteparabilismed.com
Analyst ratings
Based on 5 analysts giving stock ratings to PBLS in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PBLS in the last 3 months.
Highest
Current $34.98
$45.00 (+28.64%)
Average
$41.75 (+19.35%)
Lowest
$40.00 (+14.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Charles Zhu
LifeSci Capital
Buy
Initiated
$42.00
+20.1%
07/18/2026
Gaurav Maini
LifeSci Capital
Buy
Initiated
$42.00
+20.1%
07/18/2026
Andrew Berens
Leerink Partners
Buy
Initiated
$40.00
+14.4%
07/06/2026
Umer Raffat
Evercore ISI
Buy
Initiated
-
-
07/06/2026
Tazeen Ahmad
Bank of America Securities
Buy
Initiated
$45.00
+28.6%
07/06/2026
Michael Schmidt
Guggenheim
Buy
Initiated
$40.00
+14.4%
07/05/2026
Next call in 10 days
Tue, Aug 18, 4:00 PM
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -$0.24
Revenue / Est. (USD)
- / 16.67M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
33.90M
37.75M
Total research and development expenses
-
-
Selling, general, and admin expenses
5.28M
9.70M
Operating expense
39.18M
47.45M
Total operating expenses
39.18M
47.45M
Operating income
-39.18M
-47.45M
Other non operating income
-
-
EBT including unusual items
-38.33M
-45.32M
EBT excluding unusual items
-38.33M
-45.32M
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
-
-
Net income
-38.33M
-45.32M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
1.26M
2.43M
Interest expense
-399.00K
-292.00K
Net interest expenses
858.00K
2.14M
Depreciation and amortization charges
-
-
EBITDA
-38.53M
-46.85M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps